Trial intelligence / Profile preview

Bivalirudin vs Heparin in Elderly ACS Patients Undergoing Elective PCI

NCT04046029Phase 4Unknown

Sponsor
The First Affiliated Hospital of Dalian Medical University
Start
Jul 2019
Primary completion
Jul 2020
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bivalirudin in acute coronary syndrome (ACS), sponsored by The First Affiliated Hospital of Dalian Medical University. Status: unknown.

02

Drugs

bivalirudin
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT04046029.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04046029.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call